Intervention Review

You have free access to this content

Regimens of less than six months for treating tuberculosis

  1. Hellen Gelband*

Editorial Group: Cochrane Infectious Diseases Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 15 JUN 1999

DOI: 10.1002/14651858.CD001362

Database Title

Additional Information

How to Cite

Gelband H. Regimens of less than six months for treating tuberculosis. Cochrane Database of Systematic Reviews 1999, Issue 4. Art. No.: CD001362. DOI: 10.1002/14651858.CD001362.

Author Information

  1. Resources for the Future, Washington, DC, USA

*Hellen Gelband, Resources for the Future, 1616 P Street NW, Washington, DC, 20192, USA. Hgelband@aol.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (55K)Standard (173K)Full (211K)

References

References to studies included in this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. References to studies awaiting assessment
Agra 1981 {published data only}
  • Mehrotra ML, Gautam KD, Chaube CK. Shortest possible acceptable, effective ambulatory chemotherapy in pulmonary tuberculosis. Am Rev Respir Dis 1981;124:239-244.
Germany 1986 {published data only}
  • Eule H, Beck H, Evers H, et al. Daily ultrashort chemotherapy and intermittent short-term chemotherapy with 4 drugs of communicable pulmonary tuberculosis treated for the first time. Results of a cooperative multicenter study [Tagliche ultrakurze Chemotherapie und intermittierende Kurzzeit-Chemotherapie mit 4 Medikamenten bei erstbehandelten ansteckenden Lungentuberkulosen]. Z Erkrank Atm org 1986;167:29-41.
Hong Kong 1979a {published data only}
  • Hong Kong Chest Service, Tuberculosis Research Centre, Madras, India, and British Medical Research Council. Sputum-smear-negative pulmonary tuberculosis: Controlled trial of 3-month and 2-month regimens of chemotherapy. Lancet 1979;i:1361-1363.
Hong Kong 1979b {published data only}

 

Hong Kong 1989a {published data only}
  • Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council. A controlled trial of 3-month, 4-month, and 6-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Am Rev Respir Dis 1989;139:871-876.
Hong Kong 1989b {published data only}

 

S. India 1983 {published data only}
  • Santha T, Nazareth O, Krishnamurthy S, et al. Treatment of pulmonary tuberculosis with short course chemotherapy in South India--5-year follow up. Tubercle 1989;70:229-234.
  • Tuberculosis Research Centre. Study of chemotherapy regimens of 5 and 7 months' duration and the role of corticosteroids in the treatment of sputum-positive patients with pulmonary tuberulosis in South India. Tubercle 1983;64:73-91.
S. India 1986 {published data only}
  • Balasubramanian R, Sivasubramanian S, Vijayan VK, et al. Five year results of a 3-month and two 5-month regimens for the treatment of sputum-positive pulmonary tuberculosis in South India. Tubercle 1990;71:253-258.
  • Tuberculosis Research Centre, Madras and National Tuberculosis Institute, Bangalore. A controlled clinical trial of 3- and 5-month regimens in the treatment of sputum-positive pulmonary tuberculosis in South India. Am Rev Respir Dis 1986;134:27-33.
Singapore 1979a {published data only}
  • Singapore Tuberculosis Service/British Medical Research Council. Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. American Review of Respiratory Diseases 1979;119:579-585.
  • Singapore Tuberculosis Service/British Medical Research Council. Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis: the results up to 30 months. Tubercle 1981;62:95-102.
  • Singapore Tuberculosis Service/British Medical Research Council. Long-term follow-up of a clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. American Review of Respiratory Diseases 1986;133:779-783.
Singapore 1979b {published data only}

 

References to studies excluded from this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. References to studies awaiting assessment
East Africa 1978 {published data only}
  • East African and British Medical Research Councils. Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. Lancet 1978;ii:334-338.
France 1976 {published data only}
  • Kreis B, Pretet, Birenbaum J, et al. Two three-month treatment regimens for pulmonary tuberculosis. Bull Int Union Tuberc 1976;51:71-75.

References to studies awaiting assessment

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. References to studies awaiting assessment
Bock 2001 {published data only}
  • Bock NN, Rogers T, Tapia JR, Herron GD, DeVoe B, Geiter LJ. Acceptability of short-course rifampin and pyrazinamide treatment of latent tuberculosis infection among jail inmates. Chest 2001;119(3):833-7.
Borisova 2003 {published data only}
  • Borisova MI, Stakhanov VA, Sharkova TI, Ivashchenko NA. The use of fenazid in patients with pulmonary tuberculosis with poor isoniazid tolerance [Primenenie fenazida u bol'nykh tuberkulezom legkikh s plokhoi perenosimost'iu izoniazida]. Problemy Tuberkuleza 2003;7:34-7.
Gravendeel 2003 {published data only}
  • Gravendeel JM, Asapa AS, Becx-Bleumink M, Vrakking HA. Preliminary results of an operational field study to compare side-effects, complaints and treatment results of a single-drug short-course regimen with a four-drug fixed-dose combination (4FDC) regimen in South Sulawesi, Republic of Indonesia. Tuberculosis 2003;83(1-3):183-6.
Hernandez 1993 {published data only}
  • Hernández Forero JC. A controlled clinical trial of 4 months regimens in the shortened treatment of tuberculous pleural efusion. Apresentada a Universidad El Bosque. Facultad de Medicina para obtençao do grau de Postgrado Medicina Interna [Estudio clínico controlado de un esquema de 4 meses en el tratamiento acortado de la tuberculosis pleura]. Bogotá, D.C, 1993.
Jasmer 2002 {published data only}
  • Jasmer RM, Saukkonen JJ, Blumberg HM, Daley CL, Bernardo J, Vittinghoff, E, et al. Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial. Annals of Internal Medicine 2002;137(8):640-7.
Lwilla 2003 {published data only}
  • Lwilla F, Schellenberg D, Masanja H, Acosta C, Galindo C, Aponte J, et al. Evaluation of efficacy of community-based vs. institutional-based direct observed short-course treatment for the control of tuberculosis in Kilombero district, Tanzania. Tropical Medicine and International Health 2003;8(3):204-10.
    Direct Link:
Matteelli 1999 {published data only}
  • Matteelli A, Olliaro P, Signorini L, Cadeo G, Scalzini A, Bonazzi L, et al. Tolerability of twice-weekly rifabutin-isoniazid combinations versus daily isoniazid for latent tuberculosis in HIV-infected subjects: a pilot study. International Journal of Tuberculosis and Lung Disease 1999;3(11):1043-6.
Mawer 2001 {published data only}
  • Mawer C, Ignatenko N, Wares D, Strelis A, Golubchikova V, Yanova G, et al. Comparison of the effectiveness of WHO short-course chemotherapy and standard Russian antituberculous regimens in Tomsk, western Siberia. Lancet 2001;358(9280):445-9.
Sanchez 2004 {published data only}
  • Sanchez-Arcilla I, Vilchez JM, Garcia de la Torre M, Fernandez X, Noguerado A. Treatment of latent tuberculosis among homeless population. Comparison between wo therapeutic approaches [Infeccion tuberculosa latente en poblacion indigente. Comparacion de dos pautas terapeuticas]. Medicina Clinica (Barc) 2004;122(2):57-9.
Teo 2002 {published data only}
  • Teo SK, Tan KK, Khoo TK. Four-month chemotherapy in the treatment of smear-negative pulmonary tuberculosis: results at 30 to 60 months. Annals of the Academy of Medicine, Singapore 2002;31(2):175-81.
Yu 2001 {published data only}
  • Yu D, Wang J, Hu X. Clinical research of pasinizid on retreated sputum positive pulmonary tuberculosis in senilities. Zhonghua Jie He He Hu Xi Za Zhi 2001;24(10):608-10.
View Full Article (HTML) Summary (55K)Standard (173K)Full (211K)